AI Terminal
Spire Healthcare Group PLC
Director's Dealing • Mar 30, 2023
5328_dirs_2023-03-30_aa7b5d37-a212-4821-9935-1bbc47682045.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8254U
Spire Healthcare Group PLC
30 March 2023
30 March 2023
Spire Healthcare Group plc
Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | John Joseph Forrest | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Operating Officer | |
| b) | Initial notification /Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each GB00BNLPYF73 |
|
| b) | Nature of the transaction | Exercise of nil-cost options over ordinary shares vesting under the Spire Healthcare Group plc Long Term Incentive Plan 2014. Following the exercise by Mr Forrest of his award over 32,702 ordinary shares and after the satisfaction of taxes due, a balance of 17,332 ordinary shares were transferred to him which he has retained. |
|
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 32,702 | ||
| d) | Aggregated information - Aggregated volume - Price |
As above | |
| e) | Date of the transaction | 2023-03-29 | |
| f) | Place of the transaction | XLON |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBXGDXRSXDGXG